BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23337773)

  • 21. Tight junction proteins in human Schwann cell autotypic junctions.
    Alanne MH; Pummi K; Heape AM; Grènman R; Peltonen J; Peltonen S
    J Histochem Cytochem; 2009 Jun; 57(6):523-9. PubMed ID: 19153196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angelica injection promotes peripheral nerve structure and function recovery with increased expressions of nerve growth factor and brain derived neurotrophic factor in diabetic rats.
    Li R; Zhang J; Zhang L; Cui Q; Liu H
    Curr Neurovasc Res; 2010 Aug; 7(3):213-22. PubMed ID: 20560879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Rho-kinase inhibitor, fasudil, attenuates progressive glomerulosclerosis induced by daunorubicin in rats.
    Deng B; Yang X; Zhu Z; Zhang C
    J Huazhong Univ Sci Technolog Med Sci; 2009 Dec; 29(6):720-4. PubMed ID: 20037814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxyl fasudil, an inhibitor of Rho signaling, improves erectile function in diabetic rats: a role for neuronal ROCK.
    Sezen SF; Lagoda G; Musicki B; Burnett AL
    J Sex Med; 2014 Sep; 11(9):2164-71. PubMed ID: 24919622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of adherens junction protein p120(ctn) by 10 nM CCK precedes actin breakdown in rat pancreatic acini.
    Leser J; Beil MF; Musa OA; Adler G; Lutz MP
    Am J Physiol Gastrointest Liver Physiol; 2000 Mar; 278(3):G486-91. PubMed ID: 10712269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cilostazol on the neuropathies of streptozotocin-induced diabetic rats.
    Suh KS; Oh SJ; Woo JT; Kim SW; Yang IM; Kim JW; Kim YS; Choi YK; Park IK
    Korean J Intern Med; 1999 Jul; 14(2):34-40. PubMed ID: 10461423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats.
    Nishikimi T; Koshikawa S; Ishikawa Y; Akimoto K; Inaba C; Ishimura K; Ono H; Matsuoka H
    J Hypertens; 2007 May; 25(5):1053-63. PubMed ID: 17414670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rho kinase inhibitor improves motor dysfunction and hypoalgesia in a rat model of lumbar spinal canal stenosis.
    Ito T; Ohtori S; Hata K; Inoue G; Moriya H; Takahashi K; Yamashita T
    Spine (Phila Pa 1976); 2007 Sep; 32(19):2070-5. PubMed ID: 17762807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
    Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
    Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rho-Associated Protein Kinase-1 Mediates the Regulation of Inflammatory Markers in Diabetic Retina and in Retinal Müller Cells.
    Mohammad G; AlSharif HM; Siddiquei MM; Ahmad A; Alam K; Abu El-Asrar AM
    Ann Clin Lab Sci; 2018 Mar; 48(2):137-145. PubMed ID: 29678838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The homeodomain transcription factors Cdx1 and Cdx2 induce E-cadherin adhesion activity by reducing beta- and p120-catenin tyrosine phosphorylation.
    Ezaki T; Guo RJ; Li H; Reynolds AB; Lynch JP
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G54-65. PubMed ID: 17463179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fasudil, a Rho-Associated Coiled Coil-Forming Protein Kinase Inhibitor, Recovers Methylmercury-Induced Axonal Degeneration by Changing Microglial Phenotype in Rats.
    Fujimura M; Usuki F; Nakamura A
    Toxicol Sci; 2019 Mar; 168(1):126-136. PubMed ID: 30462329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blocking VEGF/Caveolin-1 signaling contributes to renal protection of fasudil in streptozotocin-induced diabetic rats.
    Jin J; Peng C; Wu SZ; Chen HM; Zhang BF
    Acta Pharmacol Sin; 2015 Jul; 36(7):831-40. PubMed ID: 25937636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding between the junctional proteins afadin and PLEKHA7 and implication in the formation of adherens junction in epithelial cells.
    Kurita S; Yamada T; Rikitsu E; Ikeda W; Takai Y
    J Biol Chem; 2013 Oct; 288(41):29356-68. PubMed ID: 23990464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ROCK Inhibitor Fasudil Prevents Chronic Restraint Stress-Induced Depressive-Like Behaviors and Dendritic Spine Loss in Rat Hippocampus.
    García-Rojo G; Fresno C; Vilches N; Díaz-Véliz G; Mora S; Aguayo F; Pacheco A; Parra-Fiedler N; Parra CS; Rojas PS; Tejos M; Aliaga E; Fiedler JL
    Int J Neuropsychopharmacol; 2017 Apr; 20(4):336-345. PubMed ID: 27927737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct claudins and associated PDZ proteins form different autotypic tight junctions in myelinating Schwann cells.
    Poliak S; Matlis S; Ullmer C; Scherer SS; Peles E
    J Cell Biol; 2002 Oct; 159(2):361-72. PubMed ID: 12403818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.
    Pop-Busui R; Marinescu V; Van Huysen C; Li F; Sullivan K; Greene DA; Larkin D; Stevens MJ
    Diabetes; 2002 Aug; 51(8):2619-28. PubMed ID: 12145179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. δ-Catenin dysregulation in cancer: interactions with E-cadherin and beyond.
    Lu Q
    J Pathol; 2010 Oct; 222(2):119-23. PubMed ID: 20715154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PKCα activation of p120-catenin serine 879 phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity.
    Vandenbroucke St Amant E; Tauseef M; Vogel SM; Gao XP; Mehta D; Komarova YA; Malik AB
    Circ Res; 2012 Aug; 111(6):739-49. PubMed ID: 22798526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.
    Waddingham MT; Edgley AJ; Astolfo A; Inagaki T; Fujii Y; Du CK; Zhan DY; Tsuchimochi H; Yagi N; Kelly DJ; Shirai M; Pearson JT
    Cardiovasc Diabetol; 2015 Jul; 14():92. PubMed ID: 26194354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.